HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

eriocitrin

structure in first source
Also Known As:
eriodictyol 7-O-beta-rutinoside; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (2S)-
Networked: 24 relevant articles (4 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Manthey, John A: 3 articles (06/2021 - 06/2016)
2. Cesar, Thais B: 2 articles (02/2021 - 06/2016)
3. Ferreira, Paula S: 2 articles (02/2021 - 06/2016)
4. Inoue, Takashi: 2 articles (01/2021 - 01/2014)
5. Cesar, Thais Borges: 1 article (11/2022)
6. Ramos, Fernanda Maria Manzini: 1 article (11/2022)
7. Ribeiro, Carolina Barbosa: 1 article (11/2022)
8. Chen, Guoping: 1 article (01/2022)
9. Gong, Guojin: 1 article (01/2022)
10. Jing, Chengbao: 1 article (01/2022)

Related Diseases

1. Inflammation (Inflammations)
2. Muscular Atrophy (Muscle Atrophy)
3. Cicatrix (Scar)
4. Cardiovascular Diseases (Cardiovascular Disease)
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. Lipids
2. Hesperidin
3. Glucose (Dextrose)
4. eriodictyol
5. Flavonoids
6. Cyclodextrins
7. Antioxidants
8. Glucagon-Like Peptide 1 (GLP 1)
9. Biglycan
10. Cyclin D3

Related Therapies and Procedures

1. Denervation